Data / Drug companies / Leucovorin calcium
Leucovorin calcium: 18 companies and 62 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Leucovorin calcium is listed in the FDA National Drug Code Directory by 18 companies, with 62 products in commercial distribution. 59 of the products (95.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, powder, lyophilized, for solution; tablet; injection, and the newest product started marketing on October 14, 2026.
The request: Get every company that lists leucovorin calcium in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 18
- Products
- 62
- Generic (ANDA) products
- 59 (95.2%)
- Application numbers
- 25
- Routes
- Intramuscular, Intravenous, Oral
- Brand names
- Vykoura
- openFDA record search
- api.fda.gov
Companies that list leucovorin calcium
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| BluePoint Laboratories | 6 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | May 10, 2025 |
| Fresenius Kabi USA, LLC | 5 | injection, powder, lyophilized, for solution; injection | Generic drugs (ANDA) | July 27, 2018 |
| Hikma Pharmaceuticals USA Inc. | 5 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 20, 2000 |
| Hikma Pharmaceuticals USA Inc. | 5 | tablet | Generic drugs (ANDA) | February 22, 1993 |
| Meitheal Pharmaceuticals Inc. | 5 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 19, 2023 |
| Sagent Pharmaceuticals | 5 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 15, 2018 |
| Slate Run Pharmaceuticals, LLC | 5 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 27, 2024 |
| Epic Pharma, LLC | 4 | tablet | Generic drugs (ANDA) | January 1, 2021 |
| Ingenus Pharmaceuticals, LLC | 4 | tablet | Generic drugs (ANDA) | July 30, 2020 |
| Leading Pharma, LLC | 4 | tablet | Generic drugs (ANDA) | November 16, 2020 |
| Avyxa Pharma, LLC | 3 | injection | New drug applications (NDA) | March 16, 2026 |
| Mylan Institutional LLC | 3 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | July 23, 2019 |
| Gland Pharma Limited | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 14, 2026 |
| Teva Pharmaceuticals USA, Inc. | 2 | tablet | Generic drugs (ANDA) | June 30, 1990 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | February 17, 2017 |
| Glenmark Pharmaceuticals Inc., USA | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 12, 2025 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | March 27, 2026 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | November 16, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, powder, lyophilized, for solution | 32 | 51.6% |
| Tablet | 22 | 35.5% |
| Injection | 5 | 8.1% |
| Injection, powder, lyophilized, for suspension | 3 | 4.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 59 | 95.2% |
| New drug applications (NDA) | 3 | 4.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Folate Analog | 62 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.